Qure.ai, Therapixel enter into distribution partnership

2021 04 22 16 35 1971 Breast Mammo Computer 400

Qure.ai and Therapixel are partnering to improve access to breast cancer detection through artificial intelligence (AI).

Through the partnership, Qure.ai will be a global distributor for Therapixel's MammoScreen, an AI-powered decision support tool for breast cancer screening. The companies said they aim to improve the accuracy and efficiency of breast cancer detection.

Page 1 of 568
Next Page